(Q74222595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Phase II study of intravenous Doxil in malignant pleural mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

malignant pleural mesothelioma

9 November 2019

main subject

1 reference

1 reference

Y Oh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Perez-Soler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F V Fossella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B S Glisson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Kurie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G L Walsh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Truong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D M Shin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

243-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958592%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006421706540

9 November 2019

exact match

0 references

cites work

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

12 December 2020

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

12 December 2020

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

12 December 2020

A review of chemotherapy trials for malignant mesothelioma

1 reference

12 December 2020

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma

1 reference

12 December 2020

Advances in the treatment of malignant pleural mesothelioma

1 reference

12 December 2020